Live Breaking News & Updates on Arrowhead Pharmaceutical
Stay updated with breaking news from Arrowhead pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report released on Monday, Benzinga reports. They currently have a $90.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Arrowhead Pharmaceuticals’ FY2028 earnings at $0.43 EPS. A number of other equities analysts […] ....
Recursion, Canaan, Metsera and more—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Chronic Hepatitis B Market Forecasted To Experience Growth By 2032, According To Delveinsight | Glaxosmithkline, Ionis Pharma, Beijing Continent Pharm... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.